Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

James Lind Alliance Priority Setting Partnerships

The role of each James Lind Alliance (JLA) Priority Setting Partnership (PSP) is to enable patients, carers and health and social care professionals to identify research questions, and then to prioritise these.

Each PSP thus consists of patients/carers, health and social care professionals and members of groups that represent all their interests.

PSPs are led by a steering group with an independent chair called a JLA adviser. Collaboration of this sort, where patients, clinicians and social care professionals together set the research agenda, is extremely rare, but vital.

After a nationwide survey to gather research questions has been done, usually over about three months, an interim priority-setting exercise takes place by email or by post, and a final priority-setting workshop held where partners debate and finally arrive at a top ten list of shared uncertainties which are most important to them.

The aim is then to 'translate' these uncertainties into research questions in order to set the national research agenda, and provide researchers and research funders with the research questions that most pressingly need to be addressed.

For more information please see also the Oxford Biomedical Research Centre website:

Please use the navigation links and the links to the external sites below to view information about specific PSPs which are being led from within the Oxford University Hospitals, in conjunction with the Oxford Biomedical Research Centre and/or Biomedical Research Unit.